PMID: 6982388Jan 1, 1981Paper

Effects of 24,25-dihydroxy-vitamin D3 on its plasma level in man

Metabolic Bone Disease & Related Research
J A KanisR G Russell

Abstract

Small doses of 24,25-dihydroxy-vitamin D3 (24,25(OH)2D3; 2 micrograms daily) given by mouth increased plasma levels of 24,25(OH)2D3 several-fold in normal subjects and in patients with metabolic bone disease. When oral treatment was stopped, or following the intravenous administration of 24,25(OH)2D3, plasma disappearance of 24,25(OH)2D3 was slow (t1/2 approx. 16 days). This suggests that the endogenous production rate of 24,25(OH)2D3 is similar to that of 1,25(OH)2D3 (less than 2 micrograms daily) but that its metabolic clearance is much slower. The slow metabolic clearance of 24,25(OH)2D3 may explain why plasma levels of this metabolite are about 100 times higher than those of 1,25(OH)2D3.

References

Jan 1, 1976·Annual Review of Biochemistry·H F DeLuca, H K Schnoes
Dec 1, 1978·Clinical Science and Molecular Medicine. Supplement·C M TaylorJ A Kanis
Aug 15, 1979·Clinica Chimica Acta; International Journal of Clinical Chemistry·C M TaylorE B Mawer
Jul 15, 1979·The Biochemical Journal·R M ShepardH F DeLuca
May 1, 1978·The Journal of Clinical Endocrinology and Metabolism·R W GrayH F DeLuca
May 27, 1978·British Medical Journal·J A KanisR G Russell
Feb 1, 1978·The Journal of Clinical Endocrinology and Metabolism·P BordierA Ryckwaert
Jan 24, 1977·Biochemical and Biophysical Research Communications·H L Henry
Jun 21, 1976·Biochemical and Biophysical Research Communications·C M TaylorP de Silva
Sep 1, 1971·Proceedings of the National Academy of Sciences of the United States of America·I T BoyleH F DeLuca
Jul 1, 1972·Proceedings of the National Academy of Sciences of the United States of America·M GarabedianI T Boyle
Feb 1, 1973·Archives of Biochemistry and Biophysics·Y Tanaka, H F Deluca
Jan 1, 1980·Contributions to Nephrology·J A KanisR G Russell
Jan 1, 1980·Contributions to Nephrology·F LlachJ W Coburn
Feb 16, 1980·British Medical Journal·R S MasonA W Norman

❮ Previous
Next ❯

Citations

Aug 12, 2008·The American Journal of Clinical Nutrition·Anthony W Norman
May 13, 2021·Current Developments in Nutrition·Matthew F Warren, Kimberly A Livingston

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.